Confo Therapeutics Expands Board with Appointment of Rob Scott as Independent Director

Confo Therapeutics Expands Board with…

Immunic, Inc. Announces Pricing of $25 Million Public Offering of Common Stock

Immunic, Inc. Announces Pricing of…

Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020

Novadip Biosciences to unveil its…

Confo Therapeutics Appoints Paolo Vicini as Chief Development Officer

Confo Therapeutics Appoints Paolo Vicini…

HORAMA appoints life sciences veteran Benedikt Timmerman as new Chairman

HORAMA appoints life sciences veteran…

Immunic, Inc. Receives First Regulatory Approval from German Health Authority BfArM to Initiate a Phase 2 Clinical Trial of its Selective Oral DHODH Inhibitor, IMU-838, in COVID-19 Patients

Immunic, Inc. Receives First Regulatory…

Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003

Novadip Biosciences Reports Positive Interim…

HORAMA appoints industry veteran Ian Catchpole as Chief Scientific Officer

HORAMA appoints industry veteran Ian…

Immunic, Inc. Announces Pricing of $15 Million Financing

Immunic, Inc. Announces Pricing of…

Aelin Therapeutics appoints Alexander Scheer, Ph.D., as Chief Scientific Officer

Aelin Therapeutics appoints Alexander Scheer,…